Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Paolo Roncucci"'
Autor:
Antonio Rizza, Francesco Negro, Tommaso Gasbarri, Roberto Arpesani, Baldassare Ferro, Paolo Roncucci, Cataldo Palmieri, Simone Sorbo, Emilio Maria Pasanisi, Marco Solinas, Sergio Berti
Publikováno v:
Cardiovascular Ultrasound, Vol 20, Iss 1, Pp 1-5 (2022)
Abstract Background Venous thromboembolism represents the third most frequent acute cardiovascular syndrome worldwide. Its clinical manifestations are deep vein thrombosis and/or pulmonary embolism. Despite a considerable mortality, diagnosis is ofte
Externí odkaz:
https://doaj.org/article/c178c28bb0ed48c9b536773950a3513d
Autor:
Lucia Vizzoni, Chiara Migone, Brunella Grassiri, Ylenia Zambito, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Roberto Crea, Semih Esin, Giovanna Batoni, Anna Maria Piras
Publikováno v:
Pharmaceutics, Vol 15, Iss 6, p 1618 (2023)
Acute respiratory distress syndrome (ARDS) is a severe complication of lung injuries, commonly associated with bacterial, fungal and viral infections, including SARS-CoV-2 viral infections. ARDS is strongly correlated with patient mortality and its c
Externí odkaz:
https://doaj.org/article/4a5ee67ca08b4c049807da43bc7c49f2
Autor:
Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, Paolo Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: The Coronavirus disease (COVID-19) pandemic is causing millions of infections and hundreds of thousands of deaths worldwide. Cumulative clinical and laboratory evidence suggest that a subset of patients with severe COVID-19 may develop a
Externí odkaz:
https://doaj.org/article/9e8bebcd1b2d49f2a1dfaa4c777d894e
Autor:
Anna Maria Piras, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Marta Bellini, Roberto Crea
Publikováno v:
Pharmaceuticals, Vol 13, Iss 12, p 425 (2020)
The SARS-CoV-2 infection is associated with pulmonary coagulopathy, which determines the deposition of fibrin in the air spaces and lung parenchyma. The resulting lung lesions compromise patient pulmonary function and increase mortality, or end in pe
Externí odkaz:
https://doaj.org/article/11734ce5fd414bb08d8d54a9bae93c39
Publikováno v:
European Heart Journal - Case Reports. 6
Background The pathological involvement of the heart is frequent in SARS-Coronavirus-2 infection (COVID-19) with various clinical and echocardiographic manifestations during the course of the disease. Case summary A 69-year-old female patient with se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0152b466b91c00b4fc7384530bf49b9b
https://doi.org/10.1093/ehjcr/ytac203
https://doi.org/10.1093/ehjcr/ytac203
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34:262-264
Despite the various parenchymal presentation of coronavirus disease 2019 (COVID-19) pneumonia, the involvement of the vascular component, the reduction of perfusion in noninjured part of the lung and secondary right to left shunt play an important ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3cf855f228af6cfba309a868263acda
https://doi.org/10.1089/jamp.2021.0024
https://doi.org/10.1089/jamp.2021.0024
Autor:
Filippo Mori, Maurizio Lugli, Marta Bellini, Ylenia Zambito, Alfonso Salvatore, Ester Ascione, Baldassare Ferro, Anna Maria Piras, Roberto Crea, Paolo Roncucci
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 13, Iss 425, p 425 (2020)
Volume 13
Issue 12
Pharmaceuticals, Vol 13, Iss 425, p 425 (2020)
Volume 13
Issue 12
The SARS-CoV-2 infection is associated with pulmonary coagulopathy, which determines the deposition of fibrin in the air spaces and lung parenchyma. The resulting lung lesions compromise patient pulmonary function and increase mortality, or end in pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b921bf2e50d3a676df92fd3053e24142
http://europepmc.org/articles/PMC7761183
http://europepmc.org/articles/PMC7761183
Autor:
Alessandro Gozzetti, Sabino Scolletta, Spartaco Sani, Edoardo Conticini, Serafina Valente, Daniela Nasso, Federico Franchi, Giorgio Iervasi, Monica Bocchia, Rossella Riccioni, Bruno Frediani, Annarosa Cuccaro, Davide Carrara, Aldo Paolicchi, Enrico Capochiani, Paolo Roncucci, Federico Simonetti, Ilaria Bertaggia
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
Background: The Coronavirus disease (COVID-19) pandemic is causing millions of infections and hundreds of thousands of deaths worldwide. Cumulative clinical and laboratory evidence suggest that a subset of patients with severe COVID-19 may develop a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac976dee4b801ce7c76679539914f7f7
https://www.frontiersin.org/article/10.3389/fmed.2020.00466/full
https://www.frontiersin.org/article/10.3389/fmed.2020.00466/full